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Total of 40 Malignant Lesions were Randomized into the two 
arms 19patients(total 22) in CCRT+ gefitinib arm have shown 
complete response in comparison to 11patients(total 18) in 
CCRT arm  
 
Conclusion: EGFR status evaluation in premalignant can be 
used as a screening tool for detection of transformation into 
malignant lesions. We can prevent this transformation by 
EGFR inhibitors. In malignant lesions it can be really 
important for the role of EGFR inhibitors .Eg Gefitinib has 
shown good results when combined with the conventional 
CCRT. 
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Purpose or Objective: Increasingly limited health care 
resources coupled with a rising incidence of oropharyngeal 
squamous cell carcinoma (OPSCC) is resulting in longer wait 
times for definitive treatment. Our objectives were to 
determine the impact of treatment delays on disease 
upstaging and outcomes in OPSCC. 
 
Material and Methods: Demographic features, number of 
days from diagnosis until surgery, and clinical and 
pathological staging information were determined for 139 
patients diagnosed with OPSCC between January 2006 and 
November 2011. Patients were stratified on the basis of 
whether or not their disease was upstaged between clinical 
and pathological T, N or M stage. Statistics were performed 
using MedCalc Statistical Software. 
 
Results: A total of 62 (45%) of patients were upstaged. 
Upstaged patients had a longer median time to surgery 
compared to non-upstaged patients (81 vs 68 days, p=0.017) 
and 21% (n=13) were upstaged to T ≥ T3 or N ≥ N1. There was 
a trend to higher incidence of margin positivity in upstaged 
patients (19%, n=12) compared to non-upstaged patients (9%, 
n=7) (p=0.141). Groups did not differ in the rate of nodal 
extracapsular extension (50% and 41%, p=0.363). Median 
overall survival (OS) for upstaged patients was 5.82 years and 
was not reached for non-upstaged patients. There was a 
trend to lower OS in upstaged patients (p=0.0746).  
 
Conclusion: Longer duration between diagnosis and surgery is 
associated with significant pathological upstaging. Allocating 
resources to reduce treatment delays may result in overall 
health care savings due to a reduced rate of requirement for 
adjuvant treatment, reduced patient morbidity, and 
improvement in disease outcomes.  
 
EP-1057  
Impact assessment of Sankol drug on the excretion of 
radioiodine-131 from patients DTC 
S. Saadatmand
1Radiotherapy Sadra Center Qom, Department of Medical 
Physics and Engineering Isfahan University of Medical 
Sciences and Healthcare Isfahan- Iran, qom, Iran Islamic 
Republic of 
1 
 
Purpose or Objective: The aim of this study was to 
investigate the impact assessment of Sankol drug on the 
excretion of 131I from patients with differentiated thyroid 
cancer (DTC). 
 
Material and Methods: Fifty-four patients with DTC who had 
normal renal function in two groups of control and 
intervention were included in this study. The herbal diuretic 
was given orally to the intervention group from 3 hours after 
the 131I administration, and then every 8 hours for 24 hours. 
The control patients received placebo with the same timing. 
The radioactivity of the urine samples from each maturation 
was measured and expressed as the percentage of the 
administered dose. Exposure from patients were measured 
after the drug administration and then at the time of 3, 9, 
15, 21 and 24 hours after the patient isolation. 
 
Results: The obtained mean percentage of activity excreted 
during 24 hours after intake of radioactive iodine in the urine 
in the intervention and control group were 68.85±4.3, 
59.11±5.3 with p<0.001 respectively. The obtained 
percentage of residual activity in the body after 24 hours was 
25.17±4.6, 19.56±3.6 with p < 0.001, respectively. Radiation 
dose rate at 300cm after 24 hours for the intervention and 
control group were 9.52±3.4 µSV/h, 11.92 ± 6.0µSV/h with p 
> 0.05, respectively. 
 
Conclusion: : Our results demonstrated that Sankol given as 
an adjuvant medication in the patients with DTC was caused 
a significant increase in urinary excretion of radioiodine and 
shorten the hospital stay. 
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Purpose or Objective: To present protocol larynx 
preservation results in patients treated for carcinoma of the 
larynx or hypopharynx in stage III and IV. 
 
Material and Methods: Data from a serie of 50 patients 
treated under the guidance of larynx preservation protocol 
implemented at our institution in 2007 were analyzed. 
Treatment protocol is divided into two phases. Patients 
meeting the inclusion criteria receive CDDP and 5FU cycle. At 
3 weeks CT evaluation is performed. If the answer is > 50% 
are included in the arm radiochemotherapy : CDDP every 3 
weeks and RT 70Gy 2 Gy per session 5 days a week. Those 
who do not respond or <50% are scheduled to total 
laryngectomy + neck dissection. If indicated received 
postoperative RT. The cases analyzed belong the period 
2007-2012 (minimum three years follow-up). All patients 
were considered evaluable.  
 
Results: The serie includes 50 patients with a median age of 
56 years. 42 men and 8 women with tumors in the larynx (28) 
and hypopharynx (22); 27 stage III and 23 stage IV. 22 not 
reached a sufficient response (<50%) and yes they got 27; in 
one case we missed the information. Laryngectomy was 
performed in 19 patients out of 22 unanswered (3 refused). 
Among the 27 respondents, received RT / CT, 6 LT for 
recurrences were performed. Larynx preservation was 
achieved in 50% of patients. The survival of the entire group 
was 51% at 5 years and 62.6% cause-specific survival. The 
specific survival at 5 years with RT / CT was 60% compared to 
65% of total laryngectomy gupo (p = 0.568).  
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Conclusion: The larynx preservation protocol achieves the 
same survival rates that total laryngectomy, contributing 50% 
of preservation of organ function. It is necessary more cases 
for a final evaluation.  
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Purpose or Objective: To robustly assess features of 
radiotherapy-induced fibrosis in patients within the 
reconstructive/plastic surgery clinic and establish a baseline 
for comparison against following treatment.  
 
Material and Methods: Patients awaiting fat-graft treatment 
for radiotherapy-induced fibrosis were assessed with regard 
to their symptomatology using a quality of life questionnaire. 
They also underwent clinical examination for functional 
impairment secondary to the fibrotic process and assessment 
of the microcirculation and mechanical properties by speckle 
contrast blood flow assessment and themographic imaging, 
durometry and skin cutometry respectively. The results were 
compared against age-matched healthy controls.  
 
Results: Health-related quality of life in these patients was 
impaired, with 36% of patients overall rating their quality as 
“fair” or “very poor”. On clinical assessment, movement of 
the neck was impaired with approximately 50% reduction in 
flexion and rotation movements. 100% of patients had 
sensory impairment in the fibrotic region. Microcirculatory 
changes were seen with increased flux (mean = 411.47 vs. 
348.83 contralaterally) and temperature (mean difference of 
1.3°C vs. control) in the regions of fibrotic change compared 
with the contralateral side and with controls respectively. 
Significant differences in hardness of skin and subcutaneous 
tissues of the neck were seen between treated and untreated 
areas and between patients and controls (51.5 vs. 16.8 
durometer units). Significant increases in the firmness and 
fatiguability of the skin were seen on cutometry and non-
significant decreases in elasticity.  
 
Conclusion: Our methods provide us with important baseline 
information about how affected our patients are by 
radiotherapy-induced fibrosis. This baseline can be compared 
post-operatively to quantify benefits afforded by fat-graft 
treatment and guide future research into the underlying 
mechanisms. 
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Purpose or Objective: To assess efficacy & toxicity of 
reduced CTV margins in the IMRT of head and neck cancers 
 
Material and Methods: Between 2010 and 2015, 83 
consecutive patients with locally advanced Head & Neck 
squamous cell cancers, treated with a radical intent with 
chemoradiation by IMRT, with reduced CTV margins were 
analysed for local control, toxicity, compliance & survival. 
Nodal delineation was as per DAHANCA guidelines.Toxicity 
was assessed by CTCAE version 4.0 
 
Results: Median age of the cohort was 58 years (32-76) with 
65 males & 18 female patients. Hypopharyngeal cancers were 
47% followed by oropharyngeal (27%) and laryngeal (26%) 
cancers. TNM stage grouping in the cohort was IVA in 72% 
followed by IVB & III. CECT based delineation of the involved 
primary and nodal volumes were expanded uniformly by 5 
mm to create the high risk CTV and this expanded by 5 mm to 
create the PTV1. Similarly the involved nodal level was 
considered as intermediate risk (PTV2) and remaining nodal 
levels as low risk (PTV3). Inverse planning was performed 
using Varian Eclipse planning system with dose constraints to 
OAR’s as per guidelines. SIB-IMRT was delivered to a dose 70, 
63 and 56Gy in 35 fractions to high, intermediate and low risk 
volumes respectively. Median overall treatment time was 
49(40-70) days. 24% of the patients received 6 fractions per 
week. Weekly Cisplatin (40mg/sqm) was given concurrently 
with IMRT except in 10 patients receiving Carboplatin (2AUC), 
90% received a minimum of 4 cycles. Grade 3 mucositis was 
seen in 40%, grade 3 dysphagia in 6%, radiation dermatitis 
was predominantly grade 2, Xerostomia was predominantly 
grade 1 in 93%, 10% required placement of nasogastric tube 
and treatment interruption. Myelosuppression of grade 3 was 
seen towards completion of treatment in 24% of the cohort, 
predominantly in total leukocyte count. A complete response 
of 90% and 86% was seen in primary and nodal disease at the 
end of the treatment and eventually in 100% and 94% in first 
three months. 3 patients needed neck dissection and showed 
residual disease. At a median follow up of 2 years, 62 
patients are controlled with an overall survival of 74.7%. 
Deaths are due to distant metastasis in 4% and 8% due to 
other medical causes.  
 
Conclusion: Reduction of CTV margin to 5 mm seems to be 
appropriate, with good loco-regional control, reduced overall 
treatment time, better compliance, reduced toxicity & 
superior outcomes. This study forms basis for a prospective 
controlled randomised study to generate further evidence. 
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Purpose or Objective: Significant shoulder dysfunction 
persists in a majority of the oral cancer patients after surgery 
even on performing active exercises. Progressive Resistive 
Exercise Training (PRET) involves gradual and incremental 
increase in resistance for improved muscular rehabilitation. 
This randomized controlled trial was done to compare active 
shoulder exercise and PRET with active exercises for shoulder 
dysfunction in patients undergoing Radiation Therapy (RT).  
 
Material and Methods: Ninety four eligible patients with 
shoulder abduction Active Range of Motion (AROM) ≤ 90° 
were randomized to either active shoulder exercises only ( 
n=47) or PRET plus active shoulder exercises (n=47). 
Resistance was gradually progressed over 6 weeks according 
to the capacity of patients in PRET arm. AROM was measured 
at week 0, 2, 4, 6 and 6 months. Shoulder Pain and Disability 
Index (SPADI) was also measured in both arms at the base 
line and after completion of the intervention at the end of 
6th week.  
 
Results: Results: Improvement in shoulder abduction AROM 
was significantly greater in the PRET Arm (mean = 73.3° ± 
14.3° at baseline to 132.5° ± 28.5° at 6 weeks) than in 
standard arm (mean = 74.8° ± 12.5° at baseline to 97.1° ± 
